Literature DB >> 18427759

Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors.

Volker Strenger1, Petra Sovinz, Herwig Lackner, Hans Jürgen Dornbusch, Helga Lingitz, Hans G Eder, Andrea Moser, Christian Urban.   

Abstract

BACKGROUND AND
PURPOSE: Radiotherapy is an integral part of various therapeutic regimens in pediatric and adult oncology. Endocrine dysfunction, neurologic and psychiatric deficits, secondary malignancies and radiation-induced necrosis are well-known possible late effects of cranial irradiation. However, only sporadic cases of radiation-induced cavernous hemangiomas (RICH) have been reported so far. PATIENTS AND METHODS: Pediatric patients who underwent cranial radiation therapy for malignant diseases between January 1980 and December 2003 were retrospectively analyzed. After the end of therapy they entered a detailed follow-up program.
RESULTS: Of 171 patients, eight (three patients with medulloblastoma, three patients with acute lymphoblastic leukemia, and one patient each with ependymoma and craniopharyngioma) developed intracerebral cavernoma 2.9-18.4 years after irradiation representing a cumulative incidence (according to the Kaplan-Meier method) of 2.24%, 3.86%, 4.95%, and 6.74% within 5, 10, 15, and 20 years following radiation therapy, respectively. In patients treated in the first 10 years of life, RICH occurred with shorter latency and significantly more often (p = 0.044) resulting in an even higher cumulative incidence.
CONCLUSION: These findings and previously published cases show that cavernous hemangiomas may occur after irradiation of the brain several years after the end of therapy irrespective of the radiation dose and type of malignancy. Particularly children < 10 years of age at the time of irradiation are at higher risk. Since patients with RICH frequently do not show symptoms but hemorrhage is a possible severe complication, imaging of the central nervous system should be performed routinely for longer follow- ups, particularly in patients who were treated as young children.

Entities:  

Mesh:

Year:  2008        PMID: 18427759     DOI: 10.1007/s00066-008-1817-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  24 in total

1.  Second cancer after total-body irradiation (TBI) in childhood.

Authors:  Pascal Pommier; Marie Pierre Sunyach; Caroline Pasteuris; Didier Frappaz; Christian Carrie
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

2.  Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach.

Authors:  Normann Willich; Iris Ernst; Hildegard Pape; Christian Rübe; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Tobias Bölling
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

Review 3.  Imaging findings in radiation therapy complications of the central nervous system.

Authors:  Tomonori Kanda; Yuichi Wakabayashi; Feibi Zeng; Yoshiko Ueno; Keitaro Sofue; Takaki Maeda; Munenobu Nogami; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2018-07-24       Impact factor: 2.374

4.  Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients.

Authors:  Erica Gastelum; Katherine Sear; Nancy Hills; Erika Roddy; Dominica Randazzo; Nassim Chettout; Christopher Hess; Jennifer Cotter; Daphne A Haas-Kogan; Heather Fullerton; Sabine Mueller
Journal:  J Child Neurol       Date:  2014-08-13       Impact factor: 1.987

5.  Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.

Authors:  Alexandra Russo; Marie Astrid Neu; Johanna Theruvath; Bettina Kron; Arthur Wingerter; Silla Hey-Koch; Yasemin Tanyildizi; Joerg Faber
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

6.  Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study.

Authors:  Matthieu Vinchon; Pierre Leblond; Sabine Caron; Isabelle Delestret; Marc Baroncini; Bernard Coche
Journal:  Childs Nerv Syst       Date:  2011-01-14       Impact factor: 1.475

7.  Detection of irreversible changes in susceptibility-weighted images after whole-brain irradiation of children.

Authors:  S Peters; R Pahl; A Claviez; O Jansen
Journal:  Neuroradiology       Date:  2013-04-16       Impact factor: 2.804

8.  Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines.

Authors:  Ina Patties; Jutta Jahns; Guido Hildebrandt; Rolf-Dieter Kortmann; Annegret Glasow
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

9.  Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study.

Authors:  V Strenger; H Lackner; R Mayer; P Sminia; P Sovinz; M Mokry; A Pilhatsch; M Benesch; W Schwinger; M Seidel; D Sperl; S Schmidt; C Urban
Journal:  Strahlenther Onkol       Date:  2013-08-22       Impact factor: 3.621

10.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.